Effects of trypanocidal treatment on echocardiographic parameters in chagas cardiomyopathy and prognostic value of wall motion score index: A BENEFIT trial echocardiographic substudy

Schmidt, André; Romano, Minna Moreira Dias; Neto, José Antônio Marin; Rao-Melacini, Purnima; Rassi, Anis Junior; Mattos, Antônio; Avezum, Álvaro Junior; Villena, Erick; Sosa-Estani, Sergio; Bonilla, Rina; Yusuf, Salim; Morillo, Carlos A; Maciel, Benedito Carlos.
J. Am. Soc. Echocardiogr ; 32(2): 286-295, Fev. 2019. tabela, gráfico
Artículo en Inglés | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1023938

Documentos relacionados

  1. Transplantation for chagas' disease: closing the knowledge gap.
  2. Effects of Trypanocidal Treatment on Echocardiographic Parameters in Chagas Cardiomyopathy and Prognostic Value of Wall Motion Score Index: A BENEFIT Trial Echocardiographic Substudy.
  3. Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.
  4. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.
  5. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association.
  6. Benznidazole for Chronic Chagas' Cardiomyopathy.
  7. Benznidazole for Chronic Chagas' Cardiomyopathy.
  8. Benznidazole for Chronic Chagas' Cardiomyopathy.
  9. Benznidazole for Chronic Chagas' Cardiomyopathy.
  10. Treatment of Chagas' Disease--Time Is Running Out.